Seven years ago, Suzanne Hebert was diagnosed with metastatic breast
cancer that spread to her liver and bones. After four rounds of
chemotherapy and decreasing response rates, she decided it was time
for a change. That change came after advice from a friend, who also
had advanced breast cancer, and was enrolled on a clinical trial at MD
The trial combined two drugs, everolimus, and a
hormone therapy called arimidex...